We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+5.8%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$42.2B
AUM Growth
-$360M
Cap. Flow
-$2.32B
Cap. Flow %
-5.5%
Top 10 Hldgs %
7.6%
Holding
2,945
New
147
Increased
1,226
Reduced
1,320
Closed
236

Sector Composition

Rank Sector Weight
1 Technology 14.48%
2 Financials 12.95%
3 Healthcare 12.03%
4 Industrials 10.73%
5 Consumer Discretionary 10.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTX icon
26
Vertex Pharmaceuticals
VRTX
$121B
$121M 0.29%
804,827
+376,093
+88% +$55.7M
TXN icon
27
Texas Instruments
TXN
$255B
$120M 0.28%
1,144,348
-48,015
-4% -$4.68M
MA icon
28
Mastercard
MA
$477B
$119M 0.28%
788,360
+72,776
+10% +$10.8M
BRK.B icon
29
Berkshire Hathaway Class B
BRK.B
$1.07T
$119M 0.28%
599,970
+19,993
+3% +$3.8M
PFE icon
30
Pfizer
PFE
$140B
$118M 0.28%
3,440,606
+159,903
+5% +$5.45M
CRM icon
31
Salesforce
CRM
$134B
$117M 0.28%
1,140,189
+95,336
+9% +$9.72M
PG icon
32
Procter & Gamble
PG
$343B
$116M 0.27%
1,261,273
+63,852
+5% +$5.74M
QCOM icon
33
Qualcomm
QCOM
$176B
$115M 0.27%
1,793,806
-357,388
-17% -$21.7M
T icon
34
AT&T
T
$165B
$114M 0.27%
3,897,762
+190,064
+5% +$5.19M
LRCX icon
35
Lam Research
LRCX
$382B
$111M 0.26%
6,041,170
-1,044,630
-15% -$20.5M
CELG
36
DELISTED
Celgene Corp
CELG
$109M 0.26%
1,047,769
+19,218
+2% +$2.17M
CMCSA icon
37
Comcast
CMCSA
$79.1B
$109M 0.26%
2,710,221
-149,245
-5% -$5.61M
GILD icon
38
Gilead Sciences
GILD
$161B
$107M 0.25%
1,498,393
+3,175
+0.2% +$241K
HYG icon
39
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$104M 0.25%
1,190,735
-1,203,780
-50% -$106M
MMM icon
40
3M
MMM
$89B
$103M 0.24%
521,964
+27,432
+6% +$5.28M
HD icon
41
Home Depot
HD
$332B
$102M 0.24%
540,116
+115,184
+27% +$19.9M
ATVI
42
DELISTED
Activision Blizzard
ATVI
$102M 0.24%
1,610,959
+269,422
+20% +$17M
PEP icon
43
PepsiCo
PEP
$186B
$101M 0.24%
843,322
+13,115
+2% +$1.5M
VLO icon
44
Valero Energy
VLO
$89.8B
$101M 0.24%
1,095,324
-1,508
-0.1% -$124K
CVS icon
45
CVS Health
CVS
$137B
$101M 0.24%
1,387,381
+211,571
+18% +$15.4M
CTSH icon
46
Cognizant
CTSH
$21.5B
$99.9M 0.24%
1,405,976
+440,643
+46% +$32.2M
WFC icon
47
Wells Fargo
WFC
$261B
$99.1M 0.23%
1,633,906
+59,128
+4% +$3.34M
RHT
48
DELISTED
Red Hat Inc
RHT
$98.8M 0.23%
822,791
+105,914
+15% +$13M
DHI icon
49
D.R. Horton
DHI
$41B
$97.4M 0.23%
1,906,258
+206,195
+12% +$9.61M
WRK
50
DELISTED
WestRock Company
WRK
$97.2M 0.23%
1,537,395
-24,755
-2% -$1.5M

Similar funds

Guggenheim Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Guggenheim Capital held 2,945 positions worth $42.2B, down 0.85% from $42.6B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.

Guggenheim Capital withdrew a net $2.32B in Q4 2017, closing 236 positions and reducing 1,320 holdings. Its most notable exit was CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF, an estimated $84.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Guggenheim Capital opened a new position in iShares China Large-Cap ETF worth $18M.

  • Guggenheim Capital's largest Q4 2017 buy was iShares China Large-Cap ETF: 389,755 shares worth $18M.
  • Guggenheim Capital added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2017, an estimated $859M increase.
  • Guggenheim Capital's biggest Q4 2017 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $106M.
  • Guggenheim Capital fully exited CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF in Q4 2017, selling an estimated $84.5M.
  • Guggenheim Capital's ten largest holdings make up 7.6% of its $42.2B portfolio in Q4 2017.
  • Guggenheim Capital opened 147 new positions and closed 236 in Q4 2017.
  • Guggenheim Capital's portfolio value fell 0.85% quarter-over-quarter to $42.2B.

Based on Guggenheim Capital's 13F filing for Q4 2017, filed 14 Feb 2018.